about
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumorsEfficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer.A case of mannitol hypersensitivity.Patterns of care in adult medulloblastoma: results of an international online survey.Extraneural metastases of medulloblastoma: desmoplastic variants may have prolonged survival.A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma.Reduced-volume radiotherapy for patients with localized intracranial nongerminoma germ cell tumors.Medulloblastoma
P50
Q33438006-D2FAC77A-A136-4DDF-BE83-16984AEE4851Q33764664-D358BC5F-0098-432D-9F96-06D0A9D84FEBQ35635056-9BA04E16-67E7-473F-BAE9-06D1FD3B1719Q38141506-D51F19D0-AC68-4112-A240-4AEB4ED2EDEEQ39159565-225F6245-90FC-46E8-BF85-0D158DF29E92Q44074926-322FD716-4501-4956-8C3F-B928DC97982DQ47756231-A561564F-9544-40DF-A751-393246EE6B8CQ48205606-6D1581E2-DDEA-4D32-BCA0-6C7F9629865AQ86064194-9CCE83F7-B968-4148-8C30-B8C6080223B8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kevin C De Braganca
@ast
Kevin C De Braganca
@en
Kevin C De Braganca
@es
Kevin C De Braganca
@nl
Kevin C De Braganca
@sl
type
label
Kevin C De Braganca
@ast
Kevin C De Braganca
@en
Kevin C De Braganca
@es
Kevin C De Braganca
@nl
Kevin C De Braganca
@sl
prefLabel
Kevin C De Braganca
@ast
Kevin C De Braganca
@en
Kevin C De Braganca
@es
Kevin C De Braganca
@nl
Kevin C De Braganca
@sl
P106
P21
P31
P496
0000-0001-7354-1244